- Not Fee assured
- Awaiting verification
Dr Mangar has trained in all aspects of oncology including radiotherapy and chemotherapy. For radiotherapy particular interest in image guided conformal radiotherapy, and high dose rate brachytherapy for prostate cancer. He is available for daily consultation. For chemotherapy, his interest lies in chemotherapy for metastatic prostate cancer and exploring new chemoradiotherapy regimes for lung cancer.
Areas of interest
Urological cancer, chemoradiotherapy for lung cancer
Current NHS consultant posts held
Image guided radiotherapy
Mangar SA, MR Sydes, Tucker HL, Coffey J. et al.
Evaluating the relationship between erectile dysfunction and dose received by the penile bulb in patients undergoing conformal radiotherapy for prostate cancer: Analysis of data from the MRC RT01 dose escalation trial.
Radiother Oncol 2006, 80:355-362.
Mangar SA, Foo K, Norman A, Shaidi M et al.
Evaluating the effect of reducing the high dose volume on toxicity of radiotherapy in the treatment of bladder cancer. Clinical Oncology 2006, 18(6):466-473.
Mangar SA, Slevin NJ, Mais KL, and Sykes AJ.
Evaluating predictive factors for determining enteral nutrition in patients receiving radical radiotherapy for head and neck cancer. Radiother Oncol 2006, 78(2):152-8.
McNair H, Coffey J, Mangar SA, et al.
A comparison of CT and ultrasound based images to localize the prostate for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2006, 63(3):678-87.
Mangar SA, Thompson A, Miles E, Huddart R, et al
The feasibility of using gold seeds to act as fiducial markers for bladder localisation during radiotherapy. British Journal of Radiology Published online before print November 22, 2006
Affiliations / memberships
MRCP, FRCR, ESTRO, AACR, British Uro-Oncology Group